Journal profile · Medicine-Rheumatology
Revue du Rhumatisme (Edition Francaise)
ISSN 1169-8330 · eISSN 1768-3130 · Elsevier
Revue du Rhumatisme (Edition Francaise): fully open access; APC about USD 2,720; review about 45 days (submission to acceptance, publisher); acceptance rate 66% (journal website); 659 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Revue du Rhumatisme (Edition Francaise) is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Musculoskeletal pain and rehabilitation, together about 37.9% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
La Revue du Rhumatisme is the major French scientific journal in its field.The journal's Editorial board encompasses clinical and research French rheumatologists from all over the country. They have specific competencies related to the large field of joint, bone and spinal disorders. Besides the Editorial board, a multinational and international scientific committee contributes to suggest editorials, research papers, reviews, and also participates in submitting articles.Starting this year in 2023, La Revue du Rhumatisme publishes in a refreshed design and in colour, six times a year, additional new headings: interview and teaching articles, congress reports, summary cards, literature reviews, as well as all important professional information in the field of rheumatology.The journal also includes monographic series: in each issue, a space is dedicated to a monographic series on a topic of interest in the field, covered in the form of reviews by the best experts of the subject.The journal is addressed to researchers, practitioners/clinicians, educators and students in the field of rheumatology, as well as other health professionals (physicians, nurses, dentists, etc.) and policy makers in France and French-speaking countries.The journal is accessible worldwide through the ScienceDirect and ClinicalKey platforms.La Revue du Rhumatisme is the journal of the French Society of Rheumatology - Societe Francaise de Rhumatologie (SFR).
From the journal's Aims & Scope
Research area (LetPub): Medicine-Rheumatology
Editor-in-chief Marie-Christophe Boissier INSERMPublisher website
Editorial board by country: none in mainland China; most named France 12 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine21.3%
- Spondyloarthritis Studies and TreatmentsMedicine9.1%
- Musculoskeletal pain and rehabilitationMedicine7.6%
- Autoimmune and Inflammatory Disorders ResearchMedicine6.9%
- Bone health and osteoporosis researchMedicine6%
- Osteoarthritis Treatment and MechanismsMedicine5.1%
- Systemic Lupus Erythematosus ResearchMedicine4.3%
- Spine and Intervertebral Disc PathologyMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Rheumatology | Q4 | 77/77 | 0th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.1LetPub ·
- CiteScore (publisher)
- 0.1Publisher website ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.08LetPub ·
- h-index
- 19OpenAlex ·
- i10-index
- 91OpenAlex ·
- 2-year mean citedness
- 0.06OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 9,984 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 144 | 27 | 179 |
| 2025 | 659 | 56 | 270 |
| 2024 | 615 | 48 | 241 |
| 2023 | 729 | 62 | 185 |
| 2022 | 585 | 87 | 248 |
| 2021 | 707 | 97 | 239 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
45 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Acceptance rate (publisher)
- 66%Publisher website ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 16 daysPublisher website ·
- Submission to acceptance
- 45 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,720 / EUR 2,480 / GBP 2,180 / JPY 337,360 | — | — | |
| Publisher website | USD 2,720 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 2,720 (excluding taxes). The amount you pay may be reduced during submission if applicable.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 1169-8330
- Electronic ISSN
- 1768-3130
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Revue du Rhumatisme (Edition Francaise)
How long does peer review take at Revue du Rhumatisme (Edition Francaise)?
The publisher reports about 45 days (submission to acceptance); the journal's website gives an acceptance rate of 66%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Revue du Rhumatisme (Edition Francaise) based?
Of the 12 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (12). Counted from the institutions listed on the board page; for reference only.
Which databases index Revue du Rhumatisme (Edition Francaise)?
According to LetPub and DOAJ records, Revue du Rhumatisme (Edition Francaise) is indexed in Scopus.
Is Revue du Rhumatisme (Edition Francaise) open access, and what is the APC?
Revue du Rhumatisme (Edition Francaise) is a fully open-access journal. APC about USD 2,720.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .